OptimizeRx Corp — Director's Dealing 2019

Oct 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-09-30

Reporting Person: Lang James Paul (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-30	Common Stock	A	2084	—	Acquired	22924	Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.